ConductScience.org, home

Paper856255

Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid.

Wei CM and 1 other. Biochemistry, 1977. Cited by 234 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Papers, record 856255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856255

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid.
PubMed
Journal
Biochemistry
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
234
iCite
Relative citation ratio, by iCite
3.23
iCite
Revised in PubMed
2019-06-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei CMC M
2Moss BB

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenosineMajor topic
HeLa CellsMajor topic
RNA, MessengerMajor topic
Base Sequence
Oligoribonucleotides
Poly A
Ribonucleotides

Source PubMed

Download CSV of topics

Cited by157

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.

PMIDTitleJournalYearIn PapersSource
42239405FTO separation-of-function mutations alter m6A versus m6Am demethylation selectivity on RNA.bioRxiv2026https://conductscience.org/library/papers/42239405PubMed
42136125RBM45 Preferential Binding to m6A: Simulations Suggest Synergy of RRM3 and Other Domains.J Phys Chem B2026https://conductscience.org/library/papers/42136125PubMed
41935327Unveiling the epigenetic landscape: transforming renal cell carcinoma treatment.Clin Epigenetics2026https://conductscience.org/library/papers/41935327PubMed
41738031Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.J Natl Cancer Cent2026https://conductscience.org/library/papers/41738031PubMed
41662154Mechanistic studies on HNRNPA2B1 suggest binding but not selective recognition of m6A.RNA Biol2026https://conductscience.org/library/papers/41662154PubMed
41598234Discovering, Integrating, and Reinterpreting the Molecular Logic of Life: From Classical Theories of Heredity to an Extended Functional Perspective on the Central Dogma.Life (Basel)2026https://conductscience.org/library/papers/41598234PubMed
41188020Aberrant NSUN1 activity connects m5C-RNA modification to TDP-43 neurotoxicity in ALS/FTD.Life Sci Alliance2026https://conductscience.org/library/papers/41188020PubMed
41137957FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE.Clin Exp Med2025https://conductscience.org/library/papers/41137957PubMed
41019992Role of N6-Methyladenosine (m6A) epitranscriptomic mark in regulating viral infections and target for antiviral development.Front Pharmacol2025https://conductscience.org/library/papers/41019992PubMed
40940799m6A mRNA Methylation in Hematopoiesis: The Importance of Writing, Erasing, and Reading.Cells2025https://conductscience.org/library/papers/40940799PubMed
40724951From Detection to Prediction: Advances in m6A Methylation Analysis Through Machine Learning and Deep Learning with Implications in Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40724951PubMed
40642107Potential role of N6-methyladenosine modification in circular RNA biogenesis and function in the inflammatory responses.Front Mol Med2025https://conductscience.org/library/papers/40642107PubMed
40247118Small-molecule-catalysed deamination enables transcriptome-wide profiling of N6-methyladenosine in RNA.Nat Chem2025https://conductscience.org/library/papers/40247118PubMed
40022434The m6A demethylase FTO promotes C/EBPβ-LIP translation to perform oncogenic functions in breast cancer cells.FEBS J2025https://conductscience.org/library/papers/40022434PubMed
39959203Regulatory mechanisms of m6A methylation in dilated cardiomyopathy.Am J Transl Res2025https://conductscience.org/library/papers/39959203PubMed
39831771The interplay between RNA m6A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review.Cancer Biol Med2025https://conductscience.org/library/papers/39831771PubMed
39705353Cancer mutations rewire the RNA methylation specificity of METTL3-METTL14.Sci Adv2024https://conductscience.org/library/papers/39705353PubMed
39532922METTL3 alters capping enzyme expression and its activity on ribosomal proteins.Sci Rep2024https://conductscience.org/library/papers/39532922PubMed
39037148A primer for junior trainees: Recognition of RNA modifications by RNA-binding proteins.Biochem Mol Biol Educ2024https://conductscience.org/library/papers/39037148PubMed
38764000Genetic regulation of m6A RNA methylation and its contribution in human complex diseases.Sci China Life Sci2024https://conductscience.org/library/papers/38764000PubMed

See all 157 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856255

GET https://conductscience.org/api/papers/v1/856255/cited_by?page=2